Cellectis S.A. American Depositary Shares (CLLS) Stock Price, Quote & AI Analysis
Live CLLS stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Cellectis S.A. American Depositary Shares.
TradeVae provides AI-driven analysis and real-time market intelligence for Cellectis S.A. American Depositary Shares (CLLS), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.
AI Analysis
Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.
Generating AI analysis...
Cellectis S.A. American Depositary Shares's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.
Cellectis S.A. American Depositary Shares Overview
Company information
Company Overview
Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. Sourdive and André Choulika on February 20, 1999 and is headquartered in Paris, France.
Company Details
Technical Indicators
Key technical analysis metrics and signals
Loading technical indicators...
Valuation Metrics
Key valuation ratios and comparisons
Loading valuation metrics...
Cellectis S.A. American Depositary Shares Earnings & Financial Statements
Earnings Calendar
Upcoming earnings dates and historical surprises
Loading earnings calendar...
Financial Statements
Income statements, balance sheets, and cash flow
Loading income statements...
Loading balance sheets...
Loading cash flow statements...